GlassScriptPhysician profile
Alex P Nguyen
NPI 1922069624
$33,859.61
in general payments reported to CMS, 2019-2025
97 companies · $2,881 in 2025
The $2,881 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,771 · 2020: $1,933 · 2021: $11K · 2022: $3,689 · 2023: $3,197 · 2024: $2,865 · 2025: $2,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,607 · Grant: $235 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,607.03 |
| Grant | $235.20 |
| Education | $100.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $3,452.06 | 2019-2025 | |
| Janssen Biotech, INC. | $3,396.50 | 2019-2025 | Darzalex, Rybrevant, Erleada |
| Genentech USA, INC. | $2,789.00 | 2019-2025 | Venclexta, Polivy, Columvi |
| Astrazeneca Pharmaceuticals LP | $2,542.34 | 2019-2025 | Tagrisso, Calquence, Enhertu |
| Novartis Pharmaceuticals Corporation | $1,923.18 | 2019-2025 | |
| Seagen INC. | $1,835.08 | 2019-2023 | Adcetris, Padcev |
| Pfizer INC. | $1,812.06 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,601.21 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $1,405.56 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $1,088.54 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Amgen INC. | $988.07 | 2019-2023 | Lumakras, Vectibix, Xgeva |
| Beigene USA, INC. | $870.62 | 2020-2024 | Brukinsa |
| Genzyme Corporation | $848.76 | 2019-2025 | |
| Gilead Sciences, INC. | $635.63 | 2019-2025 | Trodelvy |
| Abbvie INC. | $544.30 | 2019-2025 |
Show all 97 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $457.84 | 2019-2025 | Monjuvi, Jakafi |
| Glaxosmithkline, LLC. | $449.29 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Pharmacyclics LLC, An Abbvie Company | $438.45 | 2019-2023 | Imbruvica |
| Lilly USA, LLC | $404.98 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Pharmaceuticals, INC | $330.19 | 2019-2024 | Tecvayli, Talvey, Darzalex |
| Morphosys, US INC. | $261.94 | 2021-2024 | Monjuvi |
| Astellas Pharma US INC | $261.76 | 2020-2025 | Padcev, Vyloy |
| Springworks Therapeutics, INC. | $251.39 | 2024-2025 | Ogsiveo, Gomekli |
| Bayer Healthcare Pharmaceuticals INC. | $242.96 | 2019-2025 | |
| Boston Scientific Corporation | $237.38 | 2022-2025 | Overstitch Endoscopic Suturing System |
| Takeda Pharmaceuticals U.S.A., INC. | $229.64 | 2019-2025 | Iclusig, Fruzaqla, Ninlaro |
| Rigel Pharmaceuticals, INC. | $205.39 | 2019-2022 | |
| Deciphera Pharmaceuticals INC. | $186.47 | 2022-2023 | Qinlock |
| Jazz Pharmaceuticals INC. | $164.66 | 2019-2025 | |
| Exelixis INC. | $153.92 | 2019-2025 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $142.03 | 2019-2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.96 | 2019-2023 | Gilotrif |
| Daiichi Sankyo INC. | $136.78 | 2023-2025 | Enhertu, Datroway |
| Tersera Therapeutics LLC | $129.04 | 2019-2023 | Xermelo |
| Taiho Oncology, INC. | $128.28 | 2021-2023 | |
| Tempus Ai, INC | $128.24 | 2024-2025 | Xt Cdx |
| Array Biopharma INC | $126.19 | 2019-2023 | Mektovi, Braftovi, Lorbrena |
| Teva Pharmaceuticals USA, INC. | $117.80 | 2019-2021 | |
| Cti Biopharma Corp. | $117.79 | 2022-2023 | Vonjo |
| Pharmaessentia USA Corporation | $117.49 | 2022-2025 | Besremi |
| Clovis Oncology, INC. | $117.01 | 2019-2021 | |
| Adaptive Biotechnologies Corporation | $112.48 | 2022-2025 | Clonoseq |
| Stryker Corporation | $111.03 | 2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Aveo Pharmaceuticals, INC. | $102.36 | 2022-2025 | Fotivda |
| Servier Pharmaceuticals LLC | $102.22 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $102.12 | 2019-2023 | Libtayo |
| Emd Serono, INC. | $101.06 | 2019-2022 | |
| G1 Therapeutics, INC. | $89.53 | 2023 | Cosela |
| Sobi, INC | $81.24 | 2023-2025 | |
| Tesaro, INC. | $72.99 | 2019 | |
| Stemline Therapeutics INC. | $72.18 | 2023-2025 | Orserdu |
| Acceleron Pharma, INC. | $65.21 | 2021 | |
| Verity Pharmaceuticals INC. | $64.90 | 2023-2024 | Trelstar |
| Blueprint Medicines Corporation | $64.72 | 2020-2024 | Ayvakit |
| Kite Pharma, INC. | $64.62 | 2020-2023 | |
| Karyopharm Therapeutics INC. | $63.33 | 2023-2025 | Xpovio |
| Adc Therapeutics America, INC. | $62.87 | 2022-2024 | |
| Elekta, INC. | $58.38 | 2019 | |
| Beone Medicines USA, INC. | $52.92 | 2025 | Brukinsa |
| Geron Corporation | $52.80 | 2025 | Rytelo |
| Agios Pharmaceuticals, INC. | $51.65 | 2019-2025 | Pyrukynd |
| Dova Pharmaceuticals | $49.98 | 2020-2021 | |
| Ipsen Biopharmaceuticals, INC | $47.73 | 2019-2023 | Onivyde |
| Sirtex Medical INC | $46.26 | 2024 | Sir-Spheres Microspheres |
| Amneal Pharmaceuticals LLC | $45.85 | 2023-2025 | Alymsys, Avastin, Neupogen |
| Organogenesis INC. | $39.82 | 2021-2023 | Puraply |
| Blue Earth Diagnostics | $39.80 | 2025 | Posluma |
| Fisher & Paykel Healthcare INC | $37.28 | 2024 | Fisher & Paykel Healthcare |
| Tg Therapeutics, INC. | $31.60 | 2021 | |
| Apellis Pharmaceuticals, INC. | $30.88 | 2025 | |
| Fennec Pharmaceuticals, INC. | $29.41 | 2024 | Pedmark |
| Secura Bio, INC. | $28.79 | 2020-2022 | |
| Mylan Institutional INC. | $27.86 | 2020-2021 | |
| Aimmune Therapeutics, INC. | $27.47 | 2023 | |
| Syndax Pharmaceuticals, INC. | $27.26 | 2025 | |
| Foundation Medicine, INC. | $26.51 | 2019 | |
| Macrogenics, INC. | $25.31 | 2021 | |
| Pharmacosmos Therapeutics INC. | $23.80 | 2025 | Monoferric |
| Myovant Sciences INC. | $23.74 | 2022 | |
| Dendreon Pharmaceuticals LLC | $22.39 | 2025 | Provenge |
| Emmaus Medical, INC. | $20.56 | 2023 | Endari |
| Pharming Healthcare, INC. | $20.55 | 2022 | |
| Kyowa Kirin, INC. | $20.25 | 2022 | |
| Epizyme, INC. | $19.98 | 2022 | |
| Biocompatibles, INC. | $19.70 | 2019 | |
| Spectrum Pharmaceuticals INC. | $17.75 | 2025 | Rolvedon |
| Puma Biotechnology, INC. | $17.64 | 2025 | |
| Genmab U.S., INC. | $15.93 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $14.90 | 2019 | |
| Masimo Corporation | $14.24 | 2023 | Sedline, Set and Rainbow Set |
| Allergan, INC. | $13.81 | 2020 | |
| Novo Nordisk INC | $13.53 | 2019 | |
| Sumitomo Pharma America, INC. | $13.10 | 2023 | Orgovyx |
| Tactile Systems Technology INC | $12.96 | 2022 | |
| Ferring Pharmaceuticals INC. | $12.21 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.25 | 2020 | |
| Fortovia Therapeutics, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
Keytruda $759Pomalyst $348Kisqali $346Lenvima $284Elahere $235Opdivo $231Lynparza $210Ogsiveo $208Monjuvi $208Trodelvy $205Darzalex $199Fabhalta $198Fisher & Paykel Healthcare $186Opdualag $175Rybrevant $169Enjaymo $166Venclexta $164Overstitch Endoscopic Suturing System $157Vonjo $156Reblozyl $154Tecvayli $146Enhertu $144Verzenio $142Scemblix $129Jaypirca $129Brukinsa $124Xt Cdx $113Erleada $111Blueprint Patient Specific Instrumentation $111Aequalis Perform Reversed $111Imbruvica $109Clonoseq $99.18Besremi $91.11Welireg $90.62Cosela $89.53Ojjaara $86.11Jevtana $84.81Qinlock $83.05Lorbrena $80.19Retevmo $79.35Fotivda $78.69Talvey $78.21Jemperli $75.53Tukysa $74.67Ibrance $74.67Orgovyx $73.92Polivy $72.70Columvi $72.70Orserdu $72.18Zepzelca $68.49Akeega $66.79Trelstar $64.90Xpovio $63.33Tagrisso $63.30Talzenna $60.82Xtandi $60.82Sarclisa $58.86Padcev $58.22Braftovi $58.03Mektovi $58.03Cablivi $56.02Zejula $54.37Lunsumio $53.99Ayvakit $52.99Rytelo $52.80Nubeqa $52.42Libtayo $51.57Calquence $47.53Sir-Spheres Microspheres $46.26Promacta $42.77Tecentriq $40.61Posluma $39.80Cabometyx $34.97Ultomiris $34.67Wayrilz $31.49Alymsys $31.00Ziihera $29.54Pedmark $29.41Iclusig $29.38Blenrep $29.19Keytruda Qlex $28.99Onivyde $28.42Xofigo $28.04Gilotrif $28.01Tabrecta $27.73Vowst $27.47Xermelo $27.43Doptelet $25.49Datroway $25.17Epkinly $25.08Fruzaqla $24.76Vitrakvi $24.38Stivarga $24.38Monoferric $23.80Pyrukynd $23.11Provenge $22.39Inlyta $22.16Bavencio $22.16Carvykti $22.14Adcetris $22.13
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.